News + Events
Vyaire Medical Enters Exclusive, Five-Year Agreement to Distribute Spirosure’s Fenom Pro® Asthma Monitor in Multiple Countries
https://www.prnewswire.com/news-releases/vyaire-medical-enters-exclusive-five-year-agreement-to-distribute-spirosures-fenom-pro-asthma-monitor-in-multiple-countries-300983457.html
Spirosure Receives FDA Clearance to Sell Its Point-of-Care Asthma Monitor, Fenom Pro™
PLEASANTON, Calif., Feb. 25, 2019 — Spirosure Inc. announced today that it has received FDA clearance of its patent-protected Fenom Pro Asthma Monitor for use by allergists, immunologists and pulmonologists to help patients manage asthma by...
Subscribe to Diagnostics News + Events
Related Posts
CAIRE to Acquire MGC Diagnostics Holdings, Inc.
Portfolio Expands to Include Non-Invasive Cardiorespiratory Diagnostic Systems Ball Ground, GA,...
CAIRE Inc. Makes Donation to Northside Hospital Cherokee Fund
Gift Funds Safety Cabinet Used to Protect Lab Workers Conducting COVID-19 Rapid Testing Ball...